The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications
Open accessAbstract
BACKGROUND: Excessive generation of radical oxygen species (ROS) is a contributor to skin pathologies. Resveratrol (RSV) is a potent antioxidant. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) can ensure close contact and increase the amount of drug absorbed into the skin. In this study, RSV was loaded into SLN and NLC for dermal applications. METHODS: Nanoparticles were prepared by high shear homogenization using Compritol 888ATO, Myglyol, Poloxamer188, and Tween80. Particle size (PS), polydispersity index (PI), zeta potential (ZP), drug entrapment efficiency (EE), and production yield were determined. Differential scanning calorimetry (DSC) analysis and morphological transmission electron microscopy (TEM) examination were conducted. RSV concentration was optimized with cytotoxicity studies, and net intracellular accumulation of ROS was monitored with cytofluorimetry. The amount of RSV was determined from different layers of rat abdominal skin. RESULTS: PS of uniform RSV-SLN and RSV-NLC were determined as 287.2 nm ± 5.1 and 110.5 nm ± 1.3, respectively. ZP was -15.3 mV ± 0.4 and -13.8 mV ± 0.1 in the same order. The drug EE was 18% higher in NLC systems. TEM studies showed that the drug in the shell model was relevant for SLN, and that the melting point of the lipid in NLC was slightly lower. Concentrations below 50 μM were determined as suitable RSV concentrations for both SLN and NLC in cell culture studies. RSV-NLC showed less fluorescence, indicating less ROS production in cytofluorometric studies. Ex vivo skin studies revealed that NLC are more efficient in carrying RSV to the epidermis. CONCLUSION: This study suggests that both of the lipid nanoparticles had antioxidant properties at a concentration of 50 μM. When the two systems were compared, NLC penetrated deeper into the skin. RSV-loaded NLC with smaller PS and higher drug loading appears to be superior to SLN for dermal applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.032 · Cited by 692
Jenning, V., Thünemann, A. F., & Gohla, S. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00378-1 · Cited by 593
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 543
UV-induced reactive oxygen species in photocarcinogenesis and photoaging.
Scharffetter‐Kochanek, K., Wlaschek, M., Brenneisen, P., Schauen, M., Blaudschun, R., & Wenk, J. (1997) · PubMed · Cited by 406
Semple, S. C., Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00128-2 · Cited by 402
Encapsulation of retinoids in solid lipid nanoparticles (SLN)
Volkhard Jenning, S. H. G. (2001) · Journal of Microencapsulation · doi:10.1080/02652040010000361 · Cited by 315
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol
Teskač, K., & Kristl, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.011 · Cited by 288
Afaq, F., Adhami, V. M., & Ahmad, N. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00014-5 · Cited by 262
Photocarcinogenesis: an overview
Black, H. S., deGruijl, F. R., Forbes, P. D., Cleaver, J. E., Ananthaswamy, H. N., deFabo, E. C., Ullrich, S. E., & Tyrrell, R. M. (1997) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(97)00021-3 · Cited by 260
TEERANACHAIDEEKUL, V, MULLER, R., & JUNYAPRASERT, V (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.022 · Cited by 250
A. Dingler, R. P. B. (1999) · Journal of Microencapsulation · doi:10.1080/026520499288690 · Cited by 217
Jang, J.-H., & Surh, Y.-J. (2001) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00233-9 · Cited by 209
Skin Inflammation: Reactive Oxygen Species and the Role of Iron
Trenam, C. W., Blake, D. R., & Morris, C. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613740 · Cited by 190
van Ginkel, P. R., Sareen, D., Subramanian, L., Walker, Q., Darjatmoko, S. R., Lindstrom, M. J., Kulkarni, A., Albert, D. M., & Polans, A. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0347 · Cited by 185
Nanoparticulate Drug Delivery Systems
(2007) · CRC Press eBooks · doi:10.1201/9781420008449 · Cited by 171
Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity
Gokce, E. H., Sandri, G., Bonferoni, M. C., Rossi, S., Ferrari, F., Güneri, T., & Caramella, C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.028 · Cited by 159
Self-citationLecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin
Şenyiğit, T., Sonvico, F., Barbieri, S., Özer, Ö., Santi, P., & Colombo, P. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.013 · Cited by 157
Kaur, I. P., Kapila, M., & Agrawal, R. (2007) · Ageing Research Reviews · doi:10.1016/j.arr.2007.08.006 · Cited by 140
Portugal, M., Barak, V., Ginsburg, I., & Kohen, R. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.05.010 · Cited by 121
3D-Wound healing model: Influence of morphine and solid lipid nanoparticles
Hedtrich, S., Wolf, N. B., Heilmann, S., Weindl, G., Helfmann, J., Yahya, M. M., Stein, C., & Schäfer‐Korting, M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.001 · Cited by 117
Reactive Oxygen Species in Biological Systems: An Interdisciplinary Approach
Kennedy, J. F., & Knill, C. J. (2001) · Carbohydrate Polymers · doi:10.1016/s0144-8617(01)00197-7 · Cited by 114
Trombino, S., Cassano, R., Muzzalupo, R., Pingitore, A., Cione, E., & Picci, N. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.03.032 · Cited by 107
Ruktanonchai, U., Bejrapha, P., Sakulkhu, U., Opanasopit, P., Bunyapraphatsara, N., Junyaprasert, V. B., & Puttipipatkhachorn, S. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9193-6 · Cited by 93
Wesołowska, O., Kużdżał, M., Štrancar, J., & Michalak, K. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.06.005 · Cited by 86
Evaluation of alternative strategies to optimize ketorolac transdermal delivery
Puglia, C., Filosa, R., Peduto, A., Caprariis, P. D., Rizza, L., Bonina, F. P., & Blasi, P. (2006) · AAPS PharmSciTech · doi:10.1208/pt070364 · Cited by 83
Afzal, M., Matsugo, S., Sasai, M., Xu, B., Aoyama, K., & Takeuchi, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00641-7 · Cited by 74
Structural Characterization of Q10-Loaded Solid Lipid Nanoparticles by NMR Spectroscopy
Wissing, S. A., Müller, R. H., Manthei, L., & Mayer, C. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019291.36636.c1 · Cited by 73
Nanoparticulate Drug-Delivery Systems
Thassu, D., Pathak, Y. V., & Deleers, M. (2007) · Drugs and the pharmaceutical sciences · doi:10.1201/9781420008449.ch1 · Cited by 55
Hayes, M. E., Drummond, D. C., Hong, K., Zheng, W. W., Khorosheva, V. A., Cohen, J. A., Noble, Park, J. W., Marks, J. D., Benz, C. C., et al. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060040v · Cited by 36
Chemistry of Reactive Oxygen Species
Huie, R. E., & Neta, P. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46806-9_2 · Cited by 26
AROS-29 is involved in adaptive response to oxidative stress
Gesualdi, N. M., Chirico, G., Catanese, M. T., Pirozzi, G., & Esposito, F. (2006) · Free Radical Research · doi:10.1080/10715760600570547 · Cited by 19
Cited by
Resveratrol: A Double-Edged Sword in Health Benefits
Salehi, B., Mishra, A. P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P. V. T., Martins, N., & Sharifi-Rad, J. (2018) · Biomedicines · doi:10.3390/biomedicines6030091 · Cited by 1,129
Assadpour, E., & Mahdi Jafari, S. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1484687 · Cited by 536
Wang, S., Su, R., Nie, S., Sun, M., Zhang, J., Wu, D., & Moustaid-Moussa, N. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.10.002 · Cited by 531
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
Doktorovova, S., Souto, E. B., & Silva, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.005 · Cited by 419
Metadata
- Authors
- Gokce, E., Korkmaz, Dellera, Sandri, Bonferoni, & Ozer, O.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2012-04
- Volume
- 7
- Pages
- 1841
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2083172358
- Cited by
- 323
- References
- 35
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.